Assertio Logo.jpg
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
17 déc. 2024 08h30 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
12 déc. 2024 08h00 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Assertio Reports Third Quarter 2024 Financial Results
11 nov. 2024 16h02 HE | Assertio Holdings, Inc.
Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million  Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 ...
Assertio Logo.jpg
Assertio Provides Response to Letter from Short-seller
11 nov. 2024 07h30 HE | Assertio Holdings, Inc.
Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company Considering...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04 oct. 2024 16h05 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Assertio Reports Second Quarter 2024 Financial Results
07 août 2024 16h01 HE | Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results
Assertio Logo.jpg
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
24 juil. 2024 16h05 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
09 juil. 2024 16h30 HE | Assertio Holdings, Inc.
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
BES_Mark.jpg
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
03 juil. 2024 22h00 HE | Bragar Eagel & Squire
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc....
Assertio Logo.jpg
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
29 mai 2024 07h00 HE | Assertio Holdings, Inc.
Assertio appoints Brendan P. O'Grady as CEO